Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App-Based home care could reduce hospital readmissions

NCT ID NCT07386275

Knowledge-focused Sponsor: Germans Trias i Pujol Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a telemedicine app (eSalut) helps patients who are recovering at home instead of in the hospital. 202 adults admitted to a home hospitalization program were randomly assigned to use the app or receive standard care. Researchers tracked readmissions, complications, and patient satisfaction to see if the app improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eSalut digital platform (telemedicine app)
What this could lead to
If successful, this could show that a simple app helps patients recover at home with fewer hospital readmissions and better satisfaction.
What could go wrong
This is a single-center study with 202 participants, so results may not apply broadly. The app requires digital skills and a smartphone, which not all patients have.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

202 people

The number who actually took part.

Started

Jan 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥18 years old * Admitted to HAD * Ability to read Spanish/Catalan * Minimum digital literacy * Smartphone/tablet with Android or iOS * Ability to answer calls and handle the App * Patient or caregiver can manage the device Exclusion Criteria: * Patients living in nursing homes * Voluntary withdrawal * Complications requiring admission unrelated to study * Loss of patient or caregiver * No mobile device available

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospital at home are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hospital at home Patients admitted to hospital at home unit

Contacts and locations

Locations

  • Hospitalització a Domicili. Hospital Universitari Germans Trias i Pujol

    Badalona, Barcelona, 08916, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.